- The FDA has declared that the diabetes drug metformin may have high levels of a cancer-causing drug.
- NDMA is a cancer-causing contaminant also called N-Nitrosodimethylamine.
- If you take metformin, it’s essential to talk with the doctor about treatment options.
A new batch of metformin release medicines used to treat type 2 diabetes has been recalled due to a carcinogen called N-Nitrosodimenthylamine.
According to the Food and Drug Administration, the tablets — Metformin HCl Extended-Release Tablets, USP 750 mg — contain high levels of NDMA that exceed the FDA’s limit of 96 ng/day.
The tablets’ lot number is MET200501 and has an expiration date of July 2022.
Table of Contents
What to do if you take metformin
The FDA says patients who take metformin tablets should not stop taking the medication abruptly.
There is no short-term risk in taking the medication until you talk with the doctor about other options.
Health specialists warn that abruptly stopping the medication could have adverse health outcomes. However, there’s no short-term risk, so stick with it until you talk with the doctor about other treatment options.
I also wrote a tutorial on How Do You Get Gestational Diabetes? that you can follow.
Diabetes treatment protects against COVID-19 mortality
The journal Frontiers in Endocrinology research found that Black study participants were disproportionately more contract the virus than white participants.
COVID-19 risk factors
I recommend you to read following posts that will help you: What Are The Warning Signs Of Diabetic ketoacidosis?
Diabetes and metformin
People with diabetes are considered for 67% of deaths, suggesting that this condition had a significant effect on the risk of death.
Don’t forget to share this guide with your network on Face book and LinkedIn!
Sharing is caring ❤